Physicians' group recommends cognitive behavioral therapy before drugs for insomnia
Monday, May 2, 2016
MONDAY, May 2, 2016 (HealthDay News) -- People with long-term sleep troubles should turn to a form of psychotherapy to reboot normal sleeping patterns before trying sleeping pills, the American College of Physicians recommends.
Specifically, people with chronic insomnia should try cognitive behavioral therapy (CBT), the experts said. This treatment combines talk therapy, behavioral interventions and education. If CBT doesn't work, patients and their doctors should then decide together whether to add drug therapy, the new guidelines said.
"We know chronic insomnia is a real problem that patients present within our [doctors'] offices," said Dr. Wayne Riley, president of the American College of Physicians (ACP). "We want to get away from the overtendency to prescribe sleep medications, and clearly CBT can be a very nice tool in the toolkit."
Up to 10 percent of adults are affected by insomnia, defined as having trouble falling or staying asleep, the guideline authors said. More common in women and older adults, the condition can produce fatigue, poor thinking and mood disturbance, and takes a toll on workplace productivity, according to the college.
In issuing its first practice guideline on chronic insomnia treatment, the ACP didn't find enough evidence to directly compare behavioral therapy and drug treatment. But the group incorporated a review of published research indicating behavioral therapy is effective and can be initiated in a primary care setting.
Before recommending behavioral therapy to patients, doctors should rule out medical conditions that can cause insomnia -- including obstructive sleep apnea, restless legs syndrome and prostate gland enlargement -- and counsel patients on behavioral factors that can contribute to poor sleep, such as heavy alcohol use, Riley said.
Dr. Nathaniel Watson, president of the American Academy of Sleep Medicine, said that "the major advantage of CBT is it has long-lasting effects and teaches patients how to manage their insomnia symptoms and difficulties." Watson wasn't involved in crafting the new guidelines.
"It empowers patients to tackle their insomnia," Watson added. "And since there is no medication involved, you can avoid the cost and potential side effects of medications long-term."
The U.S. Food and Drug Administration has approved drugs such as Valium (diazepam), Ambien (zolpidem), Lunesta (eszopiclone) and Belsomra (suvorexant) for short-term use, around four to five weeks. FDA labeling also indicates that patients whose insomnia doesn't get better within seven to 10 days after taking medications should be re-evaluated by their doctors.
Riley said, "We looked at [the issue] very broadly; we don't say don't use a medication, we say, give your patient a trial... and if they come back still having problems sleeping, maybe add short-term use of a medication. We try to counsel against using [medication] longer than 10 to 14 days because we know dependence can be an issue."
Other prescription sleeping pill side effects include next-day drowsiness; "complex sleep behaviors," such as driving or eating while asleep; and allergic reactions, according to the FDA.
Cognitive behavioral therapy for insomnia is typically administered by physicians or psychologists trained in this type of psychotherapy, Riley said. Between four and six sessions of behavioral therapy are typically needed to improve insomnia, he said. Most health insurers cover the treatment, with an out-of-pocket cost of $45 to $100 per session if there's no coverage, he added.
Comparatively, prescription sleep medications typically cost $50 to $100 for one month's supply, Riley noted.
Watson said that inexpensive apps are also available online to help with sleep, including Sleepio and ShutEye.
Watson explained that behavioral therapy for insomnia typically addresses sleep hygiene issues, such as changing light levels, temperature and other parts of the person's sleep environment, as well as personal habits including reducing screen time before bed.
Patients are also taught realistic sleep expectations, he added. "Everyone has a bad night of sleep now and again. It's part of life," Watson said.
"I think right now in this country we have a low sleep IQ and it's a problem," he said. "I would encourage people to prioritize sleep in their lives, including creating a better sleep environment. The bedroom should be reserved for the three S's -- sleep, sex and sickness. And parents should model a good sleep environment, including [promoting] consistent bedtimes and wake times on weekdays and weekends."
The new guidelines were released online May 2 in the Annals of Internal Medicine.
SOURCES: Wayne Riley, M.D., president, American College of Physicians, Philadelphia; Nathaniel F. Watson, M.D., M.Sc., president, American Academy of Sleep Medicine, and professor, neurology, University of Washington, and director, Harborview Medical Center Sleep Clinic, Seattle; May 2, 2016,Annals of Internal Medicine, online
Copyright (c) 2016 HealthDay. All rights reserved.
News stories are provided by HealthDay and do not reflect the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, the U.S. Department of Health and Human Services, or federal policy.
ver historia personal en: www.cerasale.com.ar [dado de baja por la Cancillería Argentina por temas políticos, propio de la censura que rige en nuestro medio]//
weblog.maimonides.edu/farmacia/archives/UM_Informe_Autoevaluacion_FyB.pdf - //
weblog.maimonides.edu/farmacia/archives/0216_Admin_FarmEcon.pdf - //
www.proz.com/kudoz/english_to_spanish/art_literary/523942-key_factors.html - 65k - // www.llave.connmed.com.ar/portalnoticias_vernoticia.php?codigonoticia=17715 // www.frusculleda.com.ar/homepage/espanol/activities_teaching.htm // http://www.on24.com.ar/nota.aspx?idNot=36331 ||